Physician's Weekly11d
Addressing Acute Pain & Related Challenges: Will Recent FDA Approval of a Novel Non-Opioid Analgesic Be a Game Changer?
FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve ...
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Managed Healthcare Executive13d
Is Journavx a Step Forward In Pain Management or a Repeat of Past Mistakes?
Doerring, M.D., former FDA medical officer in the division of psychiatry and the founder and CEO of TaperClinic, he shares ...
pharmaphorum3d
Vertex weakens after neuropathic pain trial reads out
Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...
Seeking Alpha6d
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
In January Vertex won Food and Drug Administration approval for VX-548, Journavx® (suzetrigine ... that's in the final stages of seeking FDA approval. It makes sense Tonix is going after the ...
Managed Healthcare Executive9d
Nonopioid Pain Drug Journavx Gaining Traction With High Potential
According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...
Yahoo Finance19d
Ark Clinical Research at the Forefront of Advancing Non-Opioid Pain Research
LONG BEACH, Calif., March 19, 2025--(BUSINESS WIRE)--The FDA’s landmark approval of Journavx (suzetrigine)—the first non-opioid pain reliever in over two decades—represents a breakthrough in ...
Morningstar18d
Ark Clinical Research at the Forefront of Advancing Non-Opioid Pain Research
The FDA’s landmark approval of Journavx (suzetrigine)—the first non-opioid pain reliever in over two decades—represents a breakthrough in pain management. This breakthrough underscores the ...
Finanznachrichten6d
Tonix Pharmaceuticals Holding: Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
In January Vertex won Food and Drug Administration approval for VX-548, Journavx® (suzetrigine ... that's in the final stages of seeking FDA approval. It makes sense Tonix is going after the ...